A genetic variation identified in the APOL1 gene causes an increased susceptibility to FSGS but at the same time it helps heterozygous carriers to defend against trypanosoma brucei infections.
1. |
Duchateau PN et al. (2001) Apolipoprotein L gene family: tissue-specific expression, splicing, promoter regions; discovery of a new gene. |
2. |
Page NM et al. (2001) The human apolipoprotein L gene cluster: identification, classification, and sites of distribution. |
4. |
Monajemi H et al. (2002) The apolipoprotein L gene cluster has emerged recently in evolution and is expressed in human vascular tissue. |
5. |
Vanhamme L et al. (2003) Apolipoprotein L-I is the trypanosome lytic factor of human serum. |
6. |
Pérez-Morga D et al. (2005) Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes. |
7. |
Genovese G et al. (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. |
9. |
OMIM.ORG article Omim 603743 |